Longevity Biomedical, Inc. and FutureTech II Acquisition
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. announce business combination to create Nasdaq-listed biopharmaceutical company.
https://www.globenewswire.com/news-release/2024/09/20/2949858/0/en/Longevity-Biomedical-Inc-and-FutureTech-II-Acquisition-Corp-Announce-Business-Combination-to-Create-Nasdaq-Listed-Biopharmaceutical-Company-Focused-on-Advancing-New-Technologies-to.html

FutureTech II Acquisition Corp. Enters Zero Interest ...
On Monday, the company signed zero-interest convertible notes, issuing a total principal amount of $1,025,000, which the investors can convert ...
https://www.investing.com/news/sec-filings/futuretech-ii-acquisition-corp-enters-zero-interest-convertible-note-deal-93CH-3981007

FutureTech II Acquisition Corp. finalizes key subscription ...
The agreement, dated December 13, 2024, stipulates that Zhang will purchase 1,000,000 shares of FutureTech's Class A Common Stock at $5.00 per ...
https://www.investing.com/news/sec-filings/futuretech-ii-acquisition-corp-finalizes-key-subscription-agreement-93CH-3843916